111 related articles for article (PubMed ID: 25681318)
1. Risk profile of breast cancer following atypical hyperplasia detected through organized screening.
Buckley E; Sullivan T; Farshid G; Hiller J; Roder D
Breast; 2015 Jun; 24(3):208-12. PubMed ID: 25681318
[TBL] [Abstract][Full Text] [Related]
2. Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study.
Hartmann LC; Radisky DC; Frost MH; Santen RJ; Vierkant RA; Benetti LL; Tarabishy Y; Ghosh K; Visscher DW; Degnim AC
Cancer Prev Res (Phila); 2014 Feb; 7(2):211-7. PubMed ID: 24480577
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy.
Deshaies I; Provencher L; Jacob S; Côté G; Robert J; Desbiens C; Poirier B; Hogue JC; Vachon E; Diorio C
Breast; 2011 Feb; 20(1):50-5. PubMed ID: 20619647
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer risk factors in younger and older women.
Chun J; Pocock B; Joseph KA; El-Tamer M; Klein L; Schnabel F
Ann Surg Oncol; 2009 Jan; 16(1):96-9. PubMed ID: 18979140
[TBL] [Abstract][Full Text] [Related]
5. Significance of flat epithelial atypia on mammotome core needle biopsy: Should it be excised?
Kunju LP; Kleer CG
Hum Pathol; 2007 Jan; 38(1):35-41. PubMed ID: 17095049
[TBL] [Abstract][Full Text] [Related]
6. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
Luke C; Priest K; Roder D
Asian Pac J Cancer Prev; 2006; 7(1):69-74. PubMed ID: 16629519
[TBL] [Abstract][Full Text] [Related]
7. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of screening mammography in women with a history of lobular carcinoma in situ or atypical hyperplasia of the breast.
Houssami N; Abraham LA; Onega T; Collins LC; Sprague BL; Hill DA; Miglioretti DL
Breast Cancer Res Treat; 2014 Jun; 145(3):765-73. PubMed ID: 24800915
[TBL] [Abstract][Full Text] [Related]
9. Atypia on breast core needle biopsies: reproducibility and significance.
Darvishian F; Singh B; Simsir A; Ye W; Cangiarella JF
Ann Clin Lab Sci; 2009; 39(3):270-6. PubMed ID: 19667411
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging-guided core needle breast biopsies resulting in high-risk histopathologic findings: upstage frequency and lesion characteristics.
Weinfurtner RJ; Patel B; Laronga C; Lee MC; Falcon SL; Mooney BP; Yue B; Drukteinis JS
Clin Breast Cancer; 2015 Jun; 15(3):234-9. PubMed ID: 25579460
[TBL] [Abstract][Full Text] [Related]
11. Flat epithelial atypia on breast needle core biopsy: a retrospective study with clinical-pathological correlation.
Lee TY; Macintosh RF; Rayson D; Barnes PJ
Breast J; 2010; 16(4):377-83. PubMed ID: 20459431
[TBL] [Abstract][Full Text] [Related]
12. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
[TBL] [Abstract][Full Text] [Related]
13. Surgical excision of pure flat epithelial atypia identified on core needle breast biopsy.
Prowler VL; Joh JE; Acs G; Kiluk JV; Laronga C; Khakpour N; Lee MC
Breast; 2014 Aug; 23(4):352-6. PubMed ID: 24518220
[TBL] [Abstract][Full Text] [Related]
14. Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape.
Kader T; Hill P; Rakha EA; Campbell IG; Gorringe KL
Breast Cancer Res; 2018 May; 20(1):39. PubMed ID: 29720211
[TBL] [Abstract][Full Text] [Related]
15. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
Xu S; Wei B; Zhang H; Qing M; Bu H
Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
[TBL] [Abstract][Full Text] [Related]
16. Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women.
Degnim AC; Dupont WD; Radisky DC; Vierkant RA; Frank RD; Frost MH; Winham SJ; Sanders ME; Smith JR; Page DL; Hoskin TL; Vachon CM; Ghosh K; Hieken TJ; Denison LA; Carter JM; Hartmann LC; Visscher DW
Cancer; 2016 Oct; 122(19):2971-8. PubMed ID: 27352219
[TBL] [Abstract][Full Text] [Related]
17. Atypical hyperplastic lesions of the female breast. A long-term follow-up study.
Page DL; Dupont WD; Rogers LW; Rados MS
Cancer; 1985 Jun; 55(11):2698-708. PubMed ID: 2986821
[TBL] [Abstract][Full Text] [Related]
18. Reassessing risk models for atypical hyperplasia: age may not matter.
Mazzola E; Coopey SB; Griffin M; Polubriaginof F; Buckley JM; Parmigiani G; Garber JE; Smith BL; Gadd MA; Specht MC; Guidi A; Hughes KS
Breast Cancer Res Treat; 2017 Sep; 165(2):285-291. PubMed ID: 28589368
[TBL] [Abstract][Full Text] [Related]
19. Flat epithelial atypia and atypical ductal hyperplasia: carcinoma underestimation rate.
Ingegnoli A; d'Aloia C; Frattaruolo A; Pallavera L; Martella E; Crisi G; Zompatori M
Breast J; 2010; 16(1):55-9. PubMed ID: 19825003
[TBL] [Abstract][Full Text] [Related]
20. Upstaging of atypical ductal hyperplasia after vacuum-assisted 11-gauge stereotactic core needle biopsy.
Winchester DJ; Bernstein JR; Jeske JM; Nicholson MH; Hahn EA; Goldschmidt RA; Watkin WG; Sener SF; Bilimoria MB; Barrera E; Winchester DP
Arch Surg; 2003 Jun; 138(6):619-22; discussion 622-3. PubMed ID: 12799332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
